Biomarkers of Immunotoxicity for Environmental and Public Health Research

International Journal of Environmental Research and Public Health

Paurene Duramad¹ 

[1] Genentech, Inc., 1 DNA Way MS #59, South San Francisco, CA 94080, USA; E-Mail:

关键词: asthma;    COPD;    biomarker validation;    immunoinformatics;    Luminex;    immunome;    immunotoxicity;   

DOI  :  10.3390/ijerph8051388

来源: mdpi

【 摘 要 】

The immune response plays an important role in the pathophysiology of numerous diseases including asthma, autoimmunity and cancer. Application of biomarkers of immunotoxicity in epidemiology studies and human clinical trials can improve our understanding of the mechanisms that underlie the associations between environmental exposures and development of these immune-mediated diseases. Immunological biomarkers currently used in environmental health studies include detection of key components of innate and adaptive immunity (e.g., complement, immunoglobulin and cell subsets) as well as functional responses and activation of key immune cells. The use of high-throughput assays, including flow cytometry, Luminex, and Multi-spot cytokine detection methods can further provide quantitative analysis of immune effects. Due to the complexity and redundancy of the immune response, an integrated assessment of several components of the immune responses is needed. The rapidly expanding field of immunoinformatics will also aid in the synthesis of the vast amount of data being generated. This review discusses and provides examples of how the identification and development of immunological biomarkers for use in studies of environmental exposures and immune-mediated disorders can be achieved.

【 授权许可】

CC BY   
© 2011 by the authors; licensee MDPI, Basel, Switzerland.